These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9640813)

  • 1. Relationship between parasite load and immune responses in early stages of Leishmania donovani infection in inbred BALB/c mice.
    Wahinya DN; Mbati PA; Jomo PM; Githure JI
    East Afr Med J; 1998 Mar; 75(3):156-9. PubMed ID: 9640813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis.
    Nagill R; Mahajan R; Sharma M; Kaur S
    Parasitol Int; 2009 Dec; 58(4):359-66. PubMed ID: 19638322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
    Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs.
    Cardoso L; Schallig HD; Cordeiro-da-Silva A; Cabral M; Alunda JM; Rodrigues M
    Vet Immunol Immunopathol; 2007 May; 117(1-2):35-41. PubMed ID: 17321602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of direct agglutination test, rk39 Test, and ELISA for the diagnosis of visceral leishmaniasis.
    Mandal J; Khurana S; Dubey ML; Bhatia P; Varma N; Malla N
    Am J Trop Med Hyg; 2008 Jul; 79(1):76-8. PubMed ID: 18606766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
    Sharma SK; Dube A; Nadeem A; Khan S; Saleem I; Garg R; Mohammad O
    Vaccine; 2006 Mar; 24(11):1800-10. PubMed ID: 16310900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens.
    Afrin F; Ali N
    J Parasitol; 1998 Aug; 84(4):743-8. PubMed ID: 9714204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T; Anam K; Ali N
    Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct agglutination test with urine samples for the diagnosis of visceral leishmaniasis.
    Islam MZ; Itoh M; Mirza R; Ahmed I; Ekram AR; Sarder AH; Shamsuzzaman SM; Hashiguchi Y; Kimura E
    Am J Trop Med Hyg; 2004 Jan; 70(1):78-82. PubMed ID: 14971702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the direct agglutination test based on freeze-dried Leishmania donovani promastigotes for the serodiagnosis of visceral leishmaniasis in Sudanese patients.
    Abdallah KA; Nour BY; Schallig HD; Mergani A; Hamid Z; Elkarim AA; Saeed OK; Mohamadani AA
    Trop Med Int Health; 2004 Oct; 9(10):1127-31. PubMed ID: 15482407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.
    Wozencraft AO; Blackwell JM
    Immunology; 1987 Apr; 60(4):559-63. PubMed ID: 2953670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
    Tewary P; Pandya J; Mehta J; Sukumaran B; Madhubala R
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):241-8. PubMed ID: 15364110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum.
    Rosypal AC; Zajac AM; Troy GC; Lindsay DS
    Vet Parasitol; 2005 Jun; 130(1-2):19-27. PubMed ID: 15893066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complex mediated lesions in experimental Kala azar: an ultrastructural study.
    Jain A; Berthwal M; Tiwari V; Maitra SC
    Indian J Pathol Microbiol; 2000 Jan; 43(1):13-6. PubMed ID: 12583413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.
    Joshi J; Malla N; Kaur S
    Parasitol Int; 2014 Aug; 63(4):612-20. PubMed ID: 24747611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.